Versant Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.1K | Buy |
+256
| New | +$29.1K | ﹤0.01% | 1305 |
|
|
2023
Q3 | – | Sell |
-7
| Closed | -$505 | – | 2003 |
|
|
2023
Q2 | $505 | Sell |
7
-14
| -67% | -$1.01K | ﹤0.01% | 1834 |
|
|
2023
Q1 | $1.55K | Hold |
21
| – | – | ﹤0.01% | 1337 |
|
|
2022
Q4 | $1.4K | Sell |
21
-13
| -38% | -$869 | ﹤0.01% | 1230 |
|
|
2022
Q3 | $2K | Buy |
34
+23
| +209% | +$1.35K | ﹤0.01% | 1093 |
|
|
2022
Q2 | $1K | Hold |
11
| – | – | ﹤0.01% | 1296 |
|
|
2022
Q1 | $1K | Sell |
11
-7
| -39% | -$636 | ﹤0.01% | 1312 |
|
|
2021
Q4 | $2K | Sell |
18
-150
| -89% | -$16.7K | ﹤0.01% | 1137 |
|
|
2021
Q3 | $15K | Buy |
+168
| New | +$15K | 0.01% | 577 |
|
|
2020
Q1 | – | Sell |
-13
| Closed | – | – | 1516 |
|
|
2019
Q4 | $0 | Hold |
13
| – | – | ﹤0.01% | 1477 |
|
|
2019
Q3 | $0 | Buy |
+13
| New | – | ﹤0.01% | 1488 |
|